Publications by authors named "S Kartha"

Aim And Objective: This case report aims to describe the management of mandibular anterior teeth subjected to occlusal trauma.

Background: Occlusal trauma occurs as a result of reduced ability of the tissues to resist the occlusal forces most likely as a result of masticatory system dysfunction abnormal contact of the teeth, and prosthetic or orthodontic treatments that create occlusal interferences.

Case Description: This paper describes a case of traumatogenic occlusion seen in the dentition of a 13-year-old female patient and its management by stabilization, endodontic, and orthodontic therapy.

View Article and Find Full Text PDF

Neuropathic injury is accompanied by chronic inflammation contributing to the onset and maintenance of pain after an initial insult. In addition to their roles in promoting immune cell activation, inflammatory mediators like secretory phospholipase A (sPLA) modulate nociceptive and excitatory neuronal signaling during the initiation of pain through hydrolytic activity. Despite having a known role in glial activation and cytokine release, it is unknown if sPLA contributes to the maintenance of painful neuropathy and spinal hyperexcitability later after neural injury.

View Article and Find Full Text PDF

Painful cervical radiculopathy is characterized by chronic neuroinflammation that lowers endogenous antioxidant responses leading to the development of oxidative stress and pain after neural trauma. Therefore, antioxidants such as secoisolariciresinol diglucoside (SDG), that promote antioxidant signaling and reduce oxidative damage may also provide pain relief. This study investigated if repeated systemic administration of synthetic SDG after a painful root compression reduces the established pain, oxidative stress and spinal glial activation that are typically evident.

View Article and Find Full Text PDF

Cervical nerve root injury induces a host of inflammatory mediators in the spinal cord that initiate and maintain neuronal hyperexcitability and pain. Secretory phospholipase A2 (sPLA2) is an enzyme that has been implicated as a mediator of pain onset and maintenance in inflammation and neural injury. Although sPLA2 modulates nociception and excitatory neuronal signaling in vitro, its effects on neuronal activity and central sensitization early after painful nerve root injury are unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Treating persistent neuropathic pain is difficult with current methods often leading to toxicity and only temporary relief.
  • Researchers discovered that the enzyme secretory phospholipase-A (sPLA) becomes more active in the spinal cord after nerve injury, which can be targeted for treatment.
  • By using nanoparticles that release a sPLA inhibitor, they showed that local administration can prevent pain immediately after injury and intravenous administration can reduce pain when given within a couple of days.
View Article and Find Full Text PDF